Cargando…

Clinical Trial Accrual: Obstacles and Opportunities

Detalles Bibliográficos
Autor principal:	Rimel, B. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843106/ https://www.ncbi.nlm.nih.gov/pubmed/27200292 http://dx.doi.org/10.3389/fonc.2016.00103

Ejemplares similares

An Electronic Information Kiosk for Enhancing Patient Accrual for Cancer Clinical Trials: A Pilot and Feasibility Study
por: Black, Morgan D, et al.
Publicado: (2022)

What drives cancer clinical trial accrual? An empirical analysis of studies leading to FDA authorisation (2015–2020)
por: Jenei, Kristina, et al.
Publicado: (2022)

Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602)
por: Freedman, Rachel A., et al.
Publicado: (2018)

Cancer Clinical Trials Accrual: Missed Opportunities to Address Disparities and Missed Opportunities to Improve Outcomes for All
por: Newman, Lisa A., et al.
Publicado: (2008)

Aberrant DNA methylation in multiple myeloma: A major obstacle or an opportunity?
por: Muylaert, Catharina, et al.
Publicado: (2022)

Accrual monitoring in cardiovascular trials
por: Baldi, Ileana, et al.
Publicado: (2017)

Liquid biopsies in pediatric oncology: opportunities and obstacles
por: Sundby, R. Taylor, et al.
Publicado: (2022)

Accrual and retention of diverse patients in psychosocial cancer clinical trials
por: Hanvey, Grace Ann, et al.
Publicado: (2022)

Leveraging National Cancer Institute Programmatic Collaboration for Uterine Cervix Cancer Patient Accrual in Puerto Rico
por: Kunos, Charles A., et al.
Publicado: (2018)

Participation in Cancer Clinical Trials: Researching the Causes of Low Accrual
por: Hallquist Viale, Pamela
Publicado: (2016)

Trial-level factors affecting accrual and completion of oncology clinical trials: A systematic review
por: Hauck, Cherie L., et al.
Publicado: (2021)

Strategies for Dodging the Obstacles in CAR T Cell Therapy
por: Safarzadeh Kozani, Pooria, et al.
Publicado: (2021)

LDHA: The Obstacle to T cell responses against tumor
por: Tang, Yu, et al.
Publicado: (2022)

Accrual to Clinical Trials (ACT): A Clinical and Translational Science Award Consortium Network
por: Visweswaran, Shyam, et al.
Publicado: (2018)

Big Data in Designing Clinical Trials: Opportunities and Challenges
por: Mayo, Charles S., et al.
Publicado: (2017)

Obstacles and opportunities for the future of genomic medicine
por: Solomon, Benjamin D
Publicado: (2014)

Drugs from the Sea -Opportunities and Obstacles
por: Proksch, Peter, et al.
Publicado: (2003)

Obstacles and opportunities in Chinese pharmaceutical innovation
por: Ni, Jingyun, et al.
Publicado: (2017)

The Specific Carbohydrate Diet: Obstacle and Opportunities
por: Rufo, Paul A.
Publicado: (2022)

Accrual in supportive care trials in pediatric oncology, a challenge!
por: Schoot, R. A., et al.
Publicado: (2012)

Opportunities and obstacles in microbial synthesis of metal nanoparticles
por: Carmona, Manuel, et al.
Publicado: (2023)

Lack of timely accrual information in oncology clinical trials: a cross-sectional analysis
por: Mitchell, Aaron P, et al.
Publicado: (2014)

Facilitating accrual to cancer control and supportive care trials: the clinical research associate perspective
por: VanHoff, David, et al.
Publicado: (2013)

Opportunities and obstacles for deep learning in biology and medicine
por: Ching, Travers, et al.
Publicado: (2018)

A randomized trial of mail and email recruitment strategies for a physician survey on clinical trial accrual
por: Murphy, Caitlin C., et al.
Publicado: (2020)

Low-Overhead Accrual Failure Detector
por: Ren, Xiao, et al.
Publicado: (2012)

Accrual, Publication Bias, and the Coronavirus in 2020
por: Bates, Susan E.
Publicado: (2020)

Which Obstacles Prevent Us from Recruiting into Clinical Trials: A Survey about the Environment for Clinical Studies at a German University Hospital in a Comprehensive Cancer Center
por: Straube, Christoph, et al.
Publicado: (2017)

NCI–Clinical Trial Accrual in a Community Network Affiliated with a Designated Cancer Center
por: Kim, Daniel J., et al.
Publicado: (2020)

Opportunities and obstacles to the development of nanopharmaceuticals for human use
por: Nassiri Koopaei, Nasser, et al.
Publicado: (2016)

Verification and validation of hearing aids: Opportunity not an obstacle
por: Jorgensen, Lindsey E.
Publicado: (2016)

Advances, obstacles, and opportunities for machine learning in proteomics
por: Desaire, Heather, et al.
Publicado: (2022)

Phenotyping to Facilitate Accrual for a Cardiovascular Intervention
por: Wagholikar, Kavishwar B., et al.
Publicado: (2019)

Parkinson's Disease Research on the African Continent: Obstacles and Opportunities
por: Dekker, Marieke C. J., et al.
Publicado: (2020)

Do we want more cancer patients on clinical trials If so, what are the barriers to greater accrual
por: Vickers, Andrew J
Publicado: (2008)

The Road to CAR T-Cell Therapies for Pediatric CNS Tumors: Obstacles and New Avenues
por: Burns, Ian, et al.
Publicado: (2022)

Trials and tribulations: obstacles to clinical trial recruitment
por: Reed, N, et al.
Publicado: (2003)

Early termination of cardiovascular trials as a consequence of poor accrual: analysis of ClinicalTrials.gov 2006–2015
por: Baldi, Ileana, et al.
Publicado: (2017)

Assessment of Trends in the Design, Accrual, and Completion of Trials Registered in ClinicalTrials.gov by Sponsor Type, 2000-2019
por: Gresham, Gillian, et al.
Publicado: (2020)

Independent association of glucocorticoids with damage accrual in SLE
por: Apostolopoulos, Diane, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9v3auca57pnan458f8niqkc65a